LORANGER STEVEN R 4
4 · Edwards Lifesciences Corp · Filed May 7, 2021
Insider Transaction Report
Form 4
LORANGER STEVEN R
Director
Transactions
- Award
Common Stock
2021-05-05+2,615→ 49,580 total - Award
Director Stock Option (Right to Acquire)
2021-05-05+3,270→ 3,270 totalExercise: $91.77From: 2021-05-05Exp: 2028-05-04→ Common Stock (3,270 underlying)
Holdings
- 15,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These restricted stock units were granted on May 5, 2021 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders. The underlying common stock (net of any shares sold to cover applicable taxes) must be held until the director ceases to serve on the Issuer's Board.
- [F2]These options were granted on May 5, 2021 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and became fully exercisable on the grant date.